Sens. Elizabeth Warren, D-Mass., Cory Booker, D-N.J., and Ron Wyden, D-Ore., today urged the Food and Drug Administration to review how accurately pulse oximeters monitor blood oxygen levels, citing multiple studies suggesting they provide misleading measures to patients of color.

"In order to reduce health disparities and restore trust among communities of color, we must reevaluate the ways in which current practices and clinical tools themselves potentially worsen outcomes for people of color," the senators wrote. "With an ongoing pandemic disproportionately affecting communities of color, it can be a matter of life or death that the very device that could help these communities and their health care providers detect the need for urgent care is less likely to alert them to risks simply because of the color of their skin.”

Related News Articles

Headline
About half of U.S. health care workers have witnessed racial discrimination against patients and say discrimination against patients is a crisis or major…
Blog
Happy New Year to all! It’s exciting to experience the shift in the calendar because it’s an opportunity for us to look with optimism at what is to come.…
Headline
Chicago-based RUSH University Medical Center launched its Community Health Workers Hub in 2018 to provide CHWs with the support they need to help combat health…
Headline
The Health Insurance Marketplace for the District of Columbia is encouraging labs to remove race as a variable in the estimated glomerular filtration rate (…
Blog
I came to Washington, D.C., from Dayton, Ohio in Feb. 2020 to serve as the chief executive officer of Howard University Hospital (HUH). Keep in mind, this…
Headline
The AHA, AHIP, Alliance of Community Health Plans, American Medical Association and Kaiser Permanente have formed a coalition that will recommend strategies to…